Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 1/20 | 0.57 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7530507 | 1.00 | PDCD1 (0.57) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL7530509 | 1.00 | PDCD1 (0.57) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL7110181 | 0.95 | ALDH1A1 (0.54) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL28350879 | 0.95 | DNM1 (0.57) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL7106941 | 0.95 | DNM1 (0.57) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL7106944 | 0.95 | DNM1 (0.57) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL21457323 | 0.92 | ALDH1A1 (0.58) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL21457327 | 0.92 | ALDH1A1 (0.58) | PDCD1CD274DNM1ALDH1A1POLB | |
| SCHEMBL15371832 | 0.90 | DNM1 (0.53) | PDCD1CD274DNM1ALDH1A1MAPT | |
| SCHEMBL19829854 | 0.88 | DNM1 (0.62) | PDCD1CD274DNM1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | claimed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | claimed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | claimed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | disclosed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | PDCD1 4660/4885CD274 4342/4885DNM1 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.